BALAXI PHARMACEUTICALS LIMITED
Share Price Target & Analysis
NSE:BALAXI
VWAP
Open
Close
High
Low
52 Week High
-0.56 (-2.04%)
BALAXI
(Miscellaneous)Turnaround Potential
52 Week Low
EPS
PE
PB
Economical
Quality
Gold
Valuation
#Analysis
NSE: BALAXI Share Price Financial Analysis & Valuation
BALAXI PHARMACEUTICALS LIMITED (BALAXI) is broadly categorized in Miscellaneous segment industry which deals in Trading vertical.
It is one of Micro Cap company with Market Capitalization of Rs 505 (in Cr). Total number of free float shares are 0 (in Lacs).
BALAXI PHARMACEUTICALS LIMITED is listed on NSE with Exchange ID - INE618N01022 and trading code is NSE:BALAXI with short name Balaxi Pharma.
In the past 1 year, BALAXI PHARMACEUTICALS LIMITED has declared an equity dividend of Rs 0 per share. At the current share price of BALAXI at Rs 26.94, this results in a dividend yield of 0 %.
As per the Fundamental Analysis of NSE:BALAXI, which uses revenues, earnings, future growth, financial ratios, return on equity, profit margins, and other data to determine BALAXI underlying value and future prospects. All of this data is available in BALAXI financial statements.
Quality of the Stock: As per the fundamental analysis of NSE:BALAXI, it is clearly understood that BALAXI is Economical performer in terms of earnings and profit margins with an EPS of 0.69. NSE:BALAXI book value per share as of today is 24.06. The current price to book ratio for BALAXI as of Apr 25, 2026 is 1.12.
Valuation of the Stock: The current valuation of BALAXI stock is like Gold which means currently the stock is Overpriced. Now, it's totally depends upon the risk appetite of an investor and risk-reward ratio of BALAXI whether to BUY this stock at current valuation. The delivery percentage of BALAXI is 0% is very crucial parameter which shows that 0% investors are anticipating that the price of BALAXI share should go up with VWAP at 27.04.
Now, the main question is whether to BUY or SELL, NSE:BALAXI at current valuation.
As per latest Analysis No. #1566:-
⇑ STRONG BUY BALAXI if All Greens
⇗ BUY BALAXI (at Lower Levels) if any 2 Greens
⇒ NEUTRAL or HOLD BALAXI (With Stop Loss) if only 1 Green
⇘ SELL BALAXI if NO Green Indicator
NSE: BALAXI Share Price Today (Apr 25, 2026)
(BALAXI PHARMACEUTICALS LIMITED Daily Analysis on the basis of BALAXI Intraday Graph & Trend)
BALAXI PHARMACEUTICALS LIMITED share price moved Down by -2.04% from its previous close of Rs 27.5. BALAXI stock last traded price is 26.94. BALAXI share price trend is Down with a total of 35140 stocks traded till now. It has touched an intraday high of Rs 28.3 and an intraday low of Rs 26.51. The BALAXI trading at 26.94, Down by Rs. -0.56, or -2.04 percent which suggests that most of the Traders are anticipating that the price of BALAXI share should go Down.
NSE: BALAXI Share Price Tomorrow Prediction
(BALAXI PHARMACEUTICALS LIMITED Share Price Prediction for Tomorrow & future forecast is based on Current Trend of BALAXI)
BALAXI PHARMACEUTICALS LIMITED share price moved Down by -2.04%. BALAXI share price short term trend is Down. It suggests that BALAXI Share Price for Tomorrow remains the same with VWAP at 27.04 will be treated as stop loss for intraday traders. BALAXI PHARMACEUTICALS LIMITED Long term investors can follow the BALAXI long term trend as mentiond in future forecast table.
NSE Code |
NSE: BALAXI |
BALAXI Share Price Today |
26.94 |
BALAXI Share Price Target Prediction for 2026 ^ |
15.9 - 42.1 |
BALAXI Share Price Target Prediction for 2027*^ |
42.1 - 43.8 |
BALAXI Share Price Target Prediction for 2028*^ |
43.8 - 46 |
BALAXI Share Price Target Prediction for 2029*^ |
48 |
BALAXI Share Price Target Prediction for 2030*^ |
49 |
BALAXI Share Price Target Prediction for 2035*^ |
53 |
| BALAXI Current Book Value 2025 |
23.9 |
*BALAXI PHARMACEUTICALS LIMITED Short Term & Long Term share price target is based on current financial year earings of the company.
^BALAXI share price target prediction for 2025 2026 2027 to 2030 is based on current market scenario, future forecast & growth assumptions, they might change subject to market sentiments.
BALAXI Technical Analysis
Candlestick Pattern: @48.99| MA | Simple | Action S1 | Expo | Action E2 |
|---|---|---|---|---|
| MA_5 | 49.57 | SELL | 49.49 | SELL |
| MA_12 | 49.63 | SELL | 49.74 | SELL |
| MA_20 | 49.73 | SELL | 50.12 | SELL |
| MA_32 | 50.77 | SELL | 51.19 | SELL |
| MA_50 | 51.74 | SELL | 52.69 | SELL |
| MA_100 | 57.38 | SELL | 56.86 | SELL |
| MA_200 | 69.81 | SELL | 68.34 | SELL |
| Trend Oscillators | Value | Action |
|---|---|---|
| Bollinger Bands | 49.73 | Downtrend |
| MACD | 0.16 | BUY |
| ADX | 25.43 | Strong Trend |
| DMI (+/-) | 24.32 / 15.57 | Uptrend |
| Momentum Oscillators | Value | Action |
|---|---|---|
| RSI | 38.85 | Neutral |
| STOCHASTIC_K (Fast) | 26.22 | Neutral |
| STOCHASTIC_D (Slow) | 44.32 | Neutral |
| CCI | -79.64 | Neutral |
| PSAR | 51.1 | SELL |
| TRUE RANGE | 1.45 | BUY |
| ATR | 2.06 | BUY |
| WILLIAMS R | -92.54 | Oversold |
| TRIX | 0 | Neutral |
| STOCHASTIC RSI K | 26.15 | Neutral |
| STOCHASTIC RSI D | 68.97 | Neutral |
| MOMENTUM | -3.94 | SELL |
| Duration | Value |
|---|---|
| 1 Year | -57.12% |
| 3 Months | -23.07% |
| 1 Month | -7.44% |
| 1 Week | -0.73% |
| Action | Overall (%) |
|---|---|
| BUY | 17% |
| NEUTRAL / HOLD | 23% |
| SELL | 60% |
Most popular Questions & Answers about BALAXI
BALAXI PHARMACEUTICALS LIMITED stock last traded price is 26.94. BALAXI share price moved Down by -2.04% from its previous close of Rs 27.5.
BALAXI PHARMACEUTICALS LIMITED share price trend is Down with a total of 35140 stocks traded till now. It has touched an intraday high of Rs 64.539 and an intraday low of Rs 26.51. The BALAXI trading at 26.94, Down by Rs. -0.56, or -2.04 percent which suggests that most of the Traders are anticipating that the price of BALAXI share should go Down and the Stop Loss will be around 27.04.
The market cap of BALAXI PHARMACEUTICALS LIMITED is ₹505 (in Cr) as of Apr 24, 2026.
The current price to earning ratio for BALAXI PHARMACEUTICALS LIMITED as of Apr 24, 2026 is 49.09.
The current price to book ratio for BALAXI PHARMACEUTICALS LIMITED as of Apr 24, 2026 is 1.12.
The highest price of BALAXI PHARMACEUTICALS LIMITED stock is ₹63.9 in the last 52-week.
The lowest price of BALAXI PHARMACEUTICALS LIMITED stock is ₹15.2 in the last 52-week.
BALAXI PHARMACEUTICALS LIMITED share trading at ₹26.94, Down by Rs. -0.56, or -2.04 percent which suggests that most of the traders are anticipating that the price of BALAXI share should go Down.
In 2025, Stock price target for BALAXI PHARMACEUTICALS LIMITED (BALAXI) are ₹15.9 on downside and ₹42.1 on upside. BALAXI PHARMACEUTICALS LIMITED share price target is based on current financial year earings of the company.
In 2026, Stock price target for BALAXI PHARMACEUTICALS LIMITED (BALAXI) are ₹42.1 on downside and ₹43.8 on upside. BALAXI PHARMACEUTICALS LIMITED share price target is based on forecasted future earnings of the company.
In 2027, Stock price target for BALAXI PHARMACEUTICALS LIMITED (BALAXI) are ₹43.8 on downside and ₹46 on upside. BALAXI PHARMACEUTICALS LIMITED share price target is based on Discounted Cash Flow (DCF) method uses the projected future cash flows of the business.
In next five years, Stock price target for BALAXI PHARMACEUTICALS LIMITED (BALAXI) will be around ₹49 BALAXI PHARMACEUTICALS LIMITED share price target is based on market scenario & growth assumptions, they might change subject to market sentiments and forecasted future earnings of BALAXI.
The price of BALAXI PHARMACEUTICALS LIMITED (BALAXI) shares moved by -2.04%. The short-term trend for BALAXI share price is Down. It implies that the share price of BALAXI will stay the same tomorrow and that intraday traders should treat VWAP at 27.04 as a stop loss. Investors with a long-term outlook can track BALAXI long-term trajectory, which is indicated in the future forecast table.
Estimated DCF Value of BALAXI stock is 8.3. Compared to the current market price of 26.94 INR, the BALAXI stock is Overvalued by 69.2%.
As per the fundamental analysis of BALAXI PHARMACEUTICALS LIMITED (BALAXI), it is of Economical quality in terms of earnings and profit margins with an EPS of 0.69. BALAXI PHARMACEUTICALS LIMITED book value per share as of today is 24.06. The current price to book ratio for BALAXI as of Apr 25, 2026 is 1.12.
NSE:BALAXI News & Other Useful Information about BALAXI Share Price
Peer Comparison of NSE: BALAXI
The Peers list includes companies operating in the same industry and having comparable market cap.
Sector: Trading
| Company | Price | EPS | BV |
|---|---|---|---|
| ADANIENT | 2287.60 | 117.64 | 288.95 |
| YAARI | 16.55 | 0 | 27.1 |
| NRL | 54.66 | 0.98 | 17.25 |
| MMTC | 65.40 | 1.2 | 10.95 |
| PRECISION | 8.00 | 0 | 35.55 |
| SWANENERGY | 328.70 | 0.59 | 146.18 |
| PTC | 183.65 | 28.47 | 160.21 |
| SHAILY | 2503.10 | 30.94 | 130.62 |
| IMPAL | 1001.60 | 69.73 | 2062.59 |
| ANDREWYU | 31.35 | 0.07 | 3.82 |